G-Pump: Phase II started

Xeris began a double-blind, crossover, U.S. Phase II trial to compare a single subcutaneous infusion of 0.3, 1.2 and 2 µg/kg G-Pump vs. a single subcutaneous infusion of 0.3, 1.2 and 2 µg/kg GlucaGen...